Navidea Biopharmaceuticals (NAVB) 8-K Departure of Directors or Certain Officers

Exhibit 10.2

SCHEDULE IDENTIFYING MATERIAL DIFFERENCES BETWEEN

EMPLOYMENT AGREEMENTS

BETWEEN NEOPROBE CORPORATION AND

THE INDIVIDUALS LISTED BELOW

	Commencement Date	Termination Date	2011 Base Salary	Amount of Severance	Amount of Severance upon change of control
Frederick O. Cope	1/1/2011	12/31/2012	$245,000	$245,000	$367,500
Mark J. Pykett	11/15/2010	12/31/2011	$325,000	$162,500	Greater of: (a) 30 months salary; or (b) $650,000
Brent L. Larson	1/1/2011	12/31/2012	$207,000	$207,000	$310,500
Anthony K. Blair	1/1/2011	12/31/2012	$195,000	$195,000	$292,500